Adi Lungu

[Michelle Starr MD MPH @mcstarr1]

Tomorrow we launch our Neonatal-Nephrology consult and follow up program. So excited (and nervous!) to get this up and running. Thankful to @IUPedsKidney @RileyChildrens and the NICU team for their support (especially @DrPaulomi)

[Int Society of Nephrology @ISNkidneycare]

🆕 @KIReports on the ISN Academy.

A monthly learning experience where one of the authors of a Kidney International Reports paper, explains the audience their research on a video recording available at the #ISNAcademy.

🎥 This month's video is out: https://t.co/eejOvJs4Lz

[UWRenalPath @UWRenalPath]

Young patient with CADASIL, and this is her renal Bx @uwpathology @koony84 @AlpersCharles @kelsmith_path @podocytes @JZRenalPath @ChangUCanSpare @maria_picken

[Jonathan Zuckerman MD PhD @JZRenalPath]

Terrible TMA. SLE patient with bloody diarrhea and AKI. Also some membranous lupus nephritis in the mix b/c one dx is never enough in #renalpath. IF is C1q.

[ASN Publications @asnpublications]

Guidelines recommend estimating #GFR from serum creatinine using an equation that includes specification of race for improved accuracy. A new study reviews the strengths and limitations of the use of race in GFR estimation and proposes a way forward https://t.co/vYfQ5KLBXD

[Adi Lungu @adilungu]

Check out "Paediatric Renovascular Education Days (PRED)" https://t.co/fdbLO0FD7H @Eventbrite

[aHUS Alliance Action @aHUSAllianceAct]

What about #aHUS aka #SHUa in the #EU? @EuRefNetwork, as the European Reference Network for Rare Kidney Diseases, has impact & reach beyond the EU re atypical HUS & TMA research. #nephrology
https://t.co/h9xtvLG5Gs #renal #research

[NephSIM @Neph_SIM]

🚨 New Case Alert 🚨

A 33 y/o with microscopic hematuria & hypocomplementemia...

https://t.co/DUcpI5nR9y

Our mnemonic for ⬇️ complement #kidney diseases: CHAMPS 🏆

C-ryo
H-eavy chain DD
A-theroembolic dz
M-PGN
P-IGN
S-LE nephritis

#FOAMed #KidneyPath #CHAMPS

[NDT @NDTsocial]

👉Overview of standardized classification and reporting of glomerulonephritis.
Read the full Review in #NDT: https://t.co/UiE61fkaud
@SethiRenalPath @fervenzafernan1 #glomerulonephritis

[Paediatric Critical Care Society @PICSociety]

*Urgent alert*

Rising no of cases presenting to #PedsICU with multi-system hyperinflammatory state, overlapping features of toxic shock syndrome & atypical Kawasaki disease, bloods consistent with severe #COVID19 - seen in both #SARSCoV2 PCR +ve AND -ve

Please share widely

[aHUS Alliance Action @aHUSAllianceAct]

Re @AlexionPharma announcement of planned study of ULTOMIRIS® (#ravulizumab-cwvz) for those hospitalized w/ severe #COVIDー19, we note its lack of global #drug access & high cost w/in #aHUS community. #COVID19 https://t.co/s1E79DVlLS #complement #eculizumab #biopharma

[NephroPlus @nephroplus]

We would like to thank all the Guests who have participated in the Indian Dialysis Olympiad 2019 and made it a huge success. We also want to thank all our sponsors and partners for their amazing support and lastly our NephroPlus teammates who have put up such an amazing event.

[Pediatric Nephrology @Ped_Neph]

🆕 The European Society for Paediatric Nephrology study of pediatric renal care in Europe: comparative analysis 1998–2017
https://t.co/Y2sHID2JvO

@HannoverMh @GreatOrmondSt @Hacettepe1967 @UZLeuven @LeuvenU
#Europe #demographics #pediatrics #nephrology #ESPN

[Michal Malina⚕️ @DrMalinaM]

Amazing buffet on the Networking dinner of #IPNA2019 in the colours of Italian flag 🇮🇹 Great venue in #Venice Arsenal | Many thanks to organisers @2019Ipna @IPNA_PedNeph

[ESPN @ESPNSociety]

Debby Gipson's take home message: if not in long-term remission by transition, nephrotic syndrome is far from the "benign" disease we were taught at medical school! (MC) #IPNA2019

[IPNA Ped Nephrology @IPNA_PedNeph]

IPNA President Pierre Cochat summaries his wonderful six years as IPNA President. Many projects and innovations leading to fulfill IPNA mission, thank you!

[American Society of Pediatric Nephrology @ASPNeph]

Dr. Michelle Rheault giving a Clinical update including new pharmacologic approaches #ipna2019 @rheault_m : ACEi or ARBs are reasonable options #ipna2019

[John D Mahan @MedEdMahan]

Caring, intelligent, thoughtful, energetic, & effective - Pierre Cochat has stimulated & overseen amazing new programs, & helped existing programs do more in his fantastic 6 yrs as IPNA President! IPNA has an even greater global impact due to his efforts @IPNA_PedNeph #IPNA2019

[VictoriaJHarkins @VictoriaJHarki1]

Sitting room only this time! Dr Devarajan Prasad in his research of NGAL and it’s value in true AKI; I didn’t understand why it doesn’t rise in pre-renal: now I do! Thanks for the laughs too #IPNA2019

[ERA - European Renal Association @ERAkidney]

Are you at #IPNA2019? Don't miss the ESPN/ERA-EDTA Registry poster (A127) “Comorbidities in European children with end-stage renal disease: ESPN/ERA-EDTA Registry data” during Poster Viewing A in "Salone Adriatico e Laguna" @EraEdtaRegistry @ESPNSociety